Adam Feuerstein, biotech reporter for STAT News, stated in a post to X: “$SLNO did not preannounce Q3 sales. That’s disappointing, as much as disclosure of preliminary Vykat XR sales for Q3 was a possibility to counter the bear thesis. Looks like we need to wait for the scheduled earnings report on Nov. 4.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO: